Mundipharma Biologics (formerly Cinfa Biotech) is part of the Mundipharma global network of independent associated companies, which operates in over 120 countries worldwide. We develop and commercialise high-quality biosimilars for oncology and inflammatory diseases.
With our offices in Pamplona, Spain and Munich, Germany we are committed to the highest European quality standards. This forms the basis for addressing the global biosimilars market.
We do our business on a fully integrated level. We cover the entire pharmaceutical value chain from development to clinical studies, and from regulatory strategy to commercialisation.
Our in-depth technical, clinical, regulatory and commercial expertise and highest European standards ensure the quality of our products. Highly efficient structures in our development enable us to quickly progress on our way to market.
Press return to search